Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Jul 25, 2006

Mylan Announces Final Approval for Additional Strengths of Estradiol Transdermal Systems

Jul 20, 2006

Mylan Announces Final Approval for Meloxicam Tablets

Jul 20, 2006

Mylan Calls for End to Abusive Practices That Delay Access to Affordable Pharmaceuticals

Jul 18, 2006

Mylan Chosen To Testify Before Congress Concerning Authorized Generics, Citizen Petitions, Declaratory Judgments And Issues Concerning The Delay Of Generic Pharmaceutical Approvals

Jul 14, 2006

Mylan Schedules First Quarter Fiscal 2007 Financial Results Conference Call and Live Webcast

Jul 13, 2006

Mylan Announces Tentative Approval for Amlodipine Besylate and Benazepril Hydrochloride Capsules

Jun 16, 2006

Mylan Declares Quarterly Cash Dividend of $.06 Per Share

May 24, 2006

Mylan Announces Tentative Approval for Sumatriptan Succinate Tablets

May 09, 2006

Mylan Reports Fiscal 2006 Adjusted Diluted EPS at the Upper End of its Previously Issued Guidance of $1.00

Apr 25, 2006

Mylan Announces Final FDA Approval for Cilostazol Tablets

Pagination

First page
Previous page
…
Page 103
Page 104
Page 105
Page 106
Current page 107
Page 108
Page 109
Page 110
Page 111
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2024 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.